The Changing Landscape of Pediatric Viral Enteropathogens in the Post-Rotavirus Vaccine Era

Natasha Halasa1, Bhinnata Piya1, Laura S Stewart1

  • 1Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

Insights

Norovirus is the most common cause of acute gastroenteritis (AGE) in children, even after rotavirus vaccine introduction. These viruses collectively cause nearly half of all pediatric AGE cases, highlighting their importance in child healthcare.

Area of Science:

  • Pediatric Infectious Diseases
  • Virology
  • Public Health

Background:

  • Acute gastroenteritis (AGE) is a frequent pediatric medical concern.
  • The viral causes of AGE require updated understanding in the post-rotavirus vaccine era, especially in outpatient settings.

Purpose of the Study:

  • To describe the viral etiology of AGE in children.
  • To compare the prevalence of norovirus, sapovirus, rotavirus, and astrovirus in children with AGE versus healthy controls.
  • To analyze viral prevalence in different healthcare settings (inpatient, emergency department, outpatient).

Main Methods:

  • Prospective enrollment of children (15 days–17 years) with AGE and healthy controls (HCs) from 2012–2015.
  • Collection and testing of stool specimens using RT-qPCR for norovirus, sapovirus, astrovirus, and Rotaclone EIA for rotavirus.
  • Frequency matching of HCs for period, age group, race, and ethnicity.

Main Results:

  • A total of 3705 AGE cases and 1563 HCs were enrolled; 2885 (78%) AGE cases and 1110 (71%) HCs provided testable stool specimens.
  • All four viruses were significantly more common in AGE cases than HCs (e.g., norovirus 22% vs 8%, P<.001).
  • Norovirus was the most frequent virus in all settings, particularly in the outpatient (OP) setting, and was more prevalent in children <5 years old.

Conclusions:

  • Norovirus is the leading viral cause of pediatric AGE, followed by sapovirus and rotavirus.
  • These four viruses (norovirus, sapovirus, rotavirus, astrovirus) are responsible for nearly half of all pediatric AGE visits.
  • Understanding viral etiologies is crucial for managing pediatric AGE, especially in the evolving post-vaccine landscape.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
160
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
186
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
868
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
147
Vaccinations01:51

Vaccinations

Overview
51.0K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
205